Alliancebernstein L.P. G1 Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $49,148 - $111,253	22,340 New	22,340 $50,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $138,976 - $292,744	-34,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.6 - $11.02 $760 - $1,102	100 Added 0.29%	34,400 $261,000
Q2 2021 Jul 30, 2021	SELL	$19.57 - $26.32 $91,979 - $123,704	-4,700 Reduced 12.05%	34,300 $753,000
Q1 2021 May 06, 2021	BUY	$17.58 - $32.59 $267,216 - $495,368	15,200 Added 63.87%	39,000 $938,000
Q4 2020 Feb 08, 2021	SELL	$10.99 - $20.4 $223,097 - $414,120	-20,300 Reduced 46.03%	23,800 $428,000
Q3 2020 Nov 12, 2020	SELL	$11.55 - $23.75 $9,240 - $19,000	-800 Reduced 1.78%	44,100 $509,000
Q4 2019 Feb 18, 2020	SELL	$20.54 - $31.0 $53,404 - $80,600	-2,600 Reduced 5.47%	44,900 $1.19 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $335,027 - $649,990	20,900 Added 78.57%	47,500 $1.46 Million
Q1 2019 May 14, 2019	SELL	$14.4 - $21.45 $37,440 - $55,770	-2,600 Reduced 8.9%	26,600 $442,000
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $11,557 - $35,931	-700 Reduced 2.34%	29,200 $559,000
Q2 2018 Aug 13, 2018	BUY	$35.06 - $51.17 $1.05 Million - $1.53 Million	29,900 New	29,900 $1.3 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.